Microbiome, Probiotics & Gut Nutrition

Greeting Message

Microbiome 2025

November 17-18, 2025| Vancouver, Canada

Conference Series LLC Ltd welcomes you to attend the 9th International Conference on Microbiome, Probiotics & Gut Nutrition to be held in Vancouver, Canada on November 17-18, 2025 . The theme for the conference this year is  "Unraveling Microbial Networks From Earth’s Ecosystems to Human Lives".

About the conference

Conference Series LLC Ltd cordially invites all the participants across the globe to attend the “8th International Conference on Microbiome, Probiotics & Gut Nutrition” during November 17-18, 2025 in Vancouver, Canada

The word "microbiome" was proposed by Joshua Lederberg to describe the biological community of harmful, commensal, and symbiotic microorganisms that really share space within our bodies.

The community of microorganisms that live in an ecosystem or organism, including bacteria, fungus, viruses, and achaea, is known as the microbiome. Everywhere scientists have investigated, including the human body, the soils and sediments of Earth, the oceans and freshwaterways, the atmosphere, and even harsh conditions like hydrothermal vents and subglacial lakes, microorganisms predominate over all other life. All of these genes linked to those life forms are collectively referred to by scientists as the microbiome.

Over 100 trillion bacteria make up the majority of us humans. There are five times as many microbes as human cells. Most of them reside in the large intestine in particular. The human genome has 200 times as many genes as all the bacteria in a single person's microbiome. A microbiome can weigh up to five pounds, and they all share a number of characteristics. They have a large and varied population, with individuals and places differing from one another. They are also dynamic, altering according on the temperature or food. Lastly, their interaction with their host is reciprocal and frequently advantageous, even necessary, for both the host and the microorganisms they are hosting.

Our bodies contain a vast variety of microorganisms on the inside as well as the outside. The largest participants are bacteria, which are known as the human microbiota. All of the genes in your microbiota make up your body's microbiome. In addition to producing vitamins including B vitamins B12, thiamine and riboflavin, and vitamin K, which is necessary for blood coagulation, the bacteria in our microbiome also aid in food digestion, immune system regulation, and defense against other pathogenic bacteria.

Microbiome: The complete genetic content of the microbiota

What is meant by Microbiota?

Protists, fungi, viruses, bacteria, and archaea are all part of the microbiota. An "ecological community of commensal, symbiotic and pathogenic microorganisms" that are present in and on all multicellular organisms that have been investigated to date, including plants and animals, is known as a microbiota. The term "microbiome" can refer to either the microorganisms themselves or the collective genomes of the microorganisms that inhabit a particular environmental niche.

Microbes should be dangerous, right?

Although some are pathogens, others only become dangerous when they multiply or end up in the unreliable area. Some are also very beneficial to the body, including when they aid in the breakdown of the variety of sugars present in human breast milk. "These sugars are not broken down by the infant." Our microbes also play important roles in immune system programming, cell nutrition, and preventing negative bacteria and viruses from colonizing our bodies.

From where do microorganisms originate?

We are sterile while in gestation, and we acquire these harmful bacteria when we are born and pass through the birth canal from our mothers. At birth, it's like a gulp. These bacteria are crucial for the beginning of the entire process, as a mother's microbiome changes during pregnancy, seemingly to a combination that is best for her unborn child. Things begin differently if you are born via cesarean section rather than vaginal delivery.

Why has the microbiome gained such popularity as a research topic?

Researchers are discovering how microbial community imbalances can lead to disease and how to correct them as a treatment as they start to define what makes a healthy microbiome. Conditions like obesity, type-2 diabetes, cirrhosis, rheumatoid arthritis, and inflammatory bowel disease are strongly linked to the human gut flora. Researchers have already used fecal transplants to reestablish the "normal" human gut microbiome in order to treat recurring Clostridium dificial infections. Other links between the gut microbiota and conditions like autism, depression, and anxiety are still being investigated by experts.

Scientists are only now starting to do systematic research on the microbiomes. They are working to understand what constitutes a healthy microbiome, including the types of microorganisms that are present and their functions, how microbiomes evolve over time, how these communities maintain equilibrium, and how changes to microbiomes affect the health of people or the environment. Even planetary science and space exploration, which are fields that are increasingly interested in microbiome research, depend on it.

In what places are microbiomes found?

The microbiome varies greatly among

The Human Microbiome:

Immunity, nutrition, and human development all depend on the microbiome. It is made up of trillions of microorganisms that reside on and within the human body. It is made up of roughly a thousand different types of bacteria that live on the skin, in the gut, vagina, and mouth. We are a "super organism" made up of both human and microbial cells because of these bacteria and the genes they express.

The Microbiome of Earth:

The soils on Earth are home to microbial populations. These subterranean homes are incredibly diverse, and based on estimations of the soil microbial population, scientists have discovered that microorganisms play a crucial role in sustaining plant life, facilitating nutrient uptake and entry into the food chain, cycling carbon and nitrogen, and decomposing contaminants.

The Ocean Microbiome:

The majority of the methane in the world's oceans is eliminated by ocean microbes. These microscopic organisms are extremely specialized and tailored to their surroundings, where they supply larger living forms with chemical building blocks and energy. Additionally, they recycle roughly the same amount of carbon dioxide from the atmosphere and create half of the oxygen humans breathe. The "nanobiome" is made up of the minuscule organisms, or "nanoplankton," that carry out these vital functions.

The Atmospheric Microbiome:

The microbiome even exists in the sky. The atmosphere is full of microbes that may float for weeks and are found everywhere. Clouds, precipitation, water supply, infectious disease, agriculture, and human health are all impacted by the movement of these bacteria around the world through the atmosphere, either freely or attached to dust or other particles.

As they explore the microbiome, scientists are finding previously unknown genes and species. The belief that microbiology plays a crucial role in the living sciences has been expanding rapidly, and microbial symbiosis is evolving from a subdiscipline to a key area of study in the life sciences.

Benefits of participation

Microbiome 2025 Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about microbiology research and its advances. This is your best opportunity to reach the largest assemblage of participants from microbiology community that is from academia, microbiology entities, medical groups, labs, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries. This conference conduct presentations, distribute information, meet with current and potential scientists, make a splash with new clinical research developments, and receive name recognition at this 2-days event. World-renowned speakers and the most recent techniques, developments, the newest updates in Microbiome, Probiotics and Gut Nutrition are hallmarks of this conference.

Who should attend and Who You’ll Meet?

Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of

• Microbiology Research Sites

• Pathologists and Immunologists

• Research Scientists

• Pharma/Biotech and Medical Device industries

• Hospitals, Labs & Associations

• Horticulture specialists

• Arborists

• Farm technicians

• Hydroponics Growers

• Environmental specialists

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals along with Academicians: University Faculties like Directors, Senior Professors/Assistant Professors/ Associate Professor, Research Scholars, investors, scientists who are related to Microbiome. Pathologists, Doctors, Director and Managers from business organizations.

Benefits of attending Microbiome 2025 Conference:

• An opportunity to meet the mentors across the world face-to-face.

• Sharing ideas, challenges and plan something interesting for future

• B2B Meetings.

• To meet the experts in the field of Microbiome.

• To share the knowledge with doctors and Scientists.

• To gain advanced knowledge in Microbiome.

• To meet investors from a different sector of Healthcare.

• To develop collaborations between Academic and Business.

• Thought to provoke talks by Doctors, Professors, Ph.D.'s and Young Researchers.

Session and Tracks

Track 1: Microbiome as a Human Organ

The human microbiome functions as a metabolic and immunological entity so vital that it is often regarded as a "virtual organ." It plays a central role in digesting complex nutrients, modulating immune responses, regulating neurotransmitters, and protecting against pathogens. The loss or imbalance of microbiota—known as dysbiosis—has been linked to numerous diseases including obesity, diabetes, autoimmune conditions, and neurological disorders. This session explores how the microbiome parallels traditional organs in function and influence, and considers its inclusion in clinical diagnostics and therapies. Emerging views challenge classical definitions of organ systems and invite reclassification of host-microbe symbiosis as an integral part of human physiology.

Track 2: The Microbiota in Early Life Shapes the Immune System

From birth, microbial exposure shapes immune cell development, especially in the gut-associated lymphoid tissue (GALT). The microbiota educates the immune system to distinguish between harmful and harmless stimuli, promoting tolerance and balanced responses. Early disruptions—due to C-section birth, formula feeding, or antibiotics—can increase risks for allergies, asthma, IBD, and autoimmune disorders. This session focuses on the critical window of microbial colonization and its long-lasting impact on immune regulation, discussing therapeutic strategies like probiotics and maternal microbiota transfer to restore optimal microbial programming in early life.

Track 3: Pediatric Microbiome: Vaginal Delivery vs. C-Section

The birth canal is a child's first major microbial exposure, profoundly influencing initial gut microbiota composition. Vaginal delivery introduces beneficial Lactobacillus and Bacteroides, while C-section births often result in skin- or hospital-derived microbiota, linked to increased risk of allergies, obesity, and immune diseases. This session examines microbial succession in infants, long-term health consequences, and interventions like vaginal swabbing or tailored probiotic supplementation that may mitigate the microbial deficit introduced by cesarean birth.

Track 4: The Gut Microbiota-Centerpiece of Human Health

Housing trillions of microbes, the gut microbiota is essential for digestion, vitamin synthesis, immune training, and inflammation control. It produces short-chain fatty acids (SCFAs), neurotransmitters like GABA and serotonin, and modulates host gene expression. Imbalances are implicated in diseases ranging from depression to metabolic syndrome. This session highlights gut microbiota functions, interactions with diet, stress, and medications, and emerging therapies that target the gut for systemic health benefits.

Track 5: The Microbiome in Cancer Development and Therapy

Microbiota can influence carcinogenesis via chronic inflammation, DNA damage, or altering immune responses. Certain bacteria like Fusobacterium nucleatum have been linked to colorectal cancer, while others enhance the efficacy of immunotherapy. This session explores the microbiome’s dual role in cancer—as a risk factor and therapeutic enhancer—and presents research on microbiome biomarkers, microbial drug metabolism, and potential interventions for cancer prevention and treatment optimization.

Track 6: The Microbiome as a Therapeutic Target for Metabolic Diseases

Obesity, type 2 diabetes, and fatty liver disease are now viewed through the lens of microbial imbalance. Specific gut microbes can influence energy extraction, lipogenesis, insulin sensitivity, and inflammation. This session discusses how diet, antibiotics, prebiotics, probiotics, and fecal microbiota transplantation (FMT) may serve as therapeutic strategies for metabolic syndrome, with emphasis on personalized microbial interventions based on individual microbiota profiles.

Track 7: Interplay Between Diet, Gut Microbiota, Epigenetic Events, and Colorectal Cancer

Diet modulates gut microbiota, which in turn produces metabolites like butyrate and secondary bile acids that influence host epigenetics. These epigenetic modifications can silence tumor suppressor genes or activate oncogenes, contributing to colorectal cancer risk. This session highlights how dietary fiber, fat, and polyphenols shape microbial outputs and epigenomic regulation, with implications for dietary prevention and personalized nutrition in cancer.

Track 8: Role of Microbial Communities in Periodontal Diseases and Caries (Oral Microbiome)

The oral cavity hosts over 700 microbial species, forming biofilms on teeth and gums. When balance shifts due to poor hygiene, diet, or genetics, pathogenic microbes like Streptococcus mutans and Porphyromonas gingivalis thrive, leading to caries and periodontitis. These conditions are linked not only to tooth loss but also to systemic issues like cardiovascular disease and diabetes. This session delves into microbial succession in the oral environment, immune evasion by pathogens, and emerging interventions like oral probiotics, vaccines, and antimicrobial peptides to restore oral microbial homeostasis.

Track 9: The Skin Microbiome

Our skin is an ecosystem populated by bacteria, fungi, and viruses that protect against invaders, regulate pH, and support immune function. Disruptions can lead to skin disorders such as eczema, acne, and psoriasis. Key players include Cutibacterium acnes, Staphylococcus epidermidis, and Malassezia spp. This session explores how skin microbiota vary by site, age, and hygiene, and how skin health can be enhanced through microbiome-preserving practices and therapeutic modulation.

Track 10: Skincare Products with Probiotics-Worth the Hype?

Probiotic skincare claims to rebalance the skin microbiome and reduce inflammation. But is there real science behind the trend? This session critically evaluates clinical evidence for topical probiotics, live biotherapeutics, and postbiotic extracts. Discussions will address regulatory challenges, delivery systems for viable microbes, and future directions in dermatocosmetics. The hype meets evidence here—what works, what doesn’t, and what’s next?

Track 11: Plant Beneficial Microbes

Rhizobacteria, endophytes, and mycorrhizal fungi form symbiotic relationships with plants, promoting growth by enhancing nutrient uptake, nitrogen fixation, and pathogen resistance. These microbes can stimulate root development, induce systemic resistance, and help plants adapt to stress. This session highlights field applications, the role of beneficial microbial consortia, and their potential in reducing synthetic fertilizer and pesticide usage.

Track 12: Harnessing PhytoMicrobiome Signaling for Microbiome Engineering

Plants release root exudates that act as chemical signals, shaping the microbial communities around them. Understanding these signals enables targeted manipulation of the phytoMicrobiome to enhance plant health. This session focuses on engineering microbiomes through breeding, genetic modification, or application of signal mimics—ushering in a new era of precision agriculture.

Track 13: Signaling in the PhytoMicrobiome

Chemical crosstalk between plants and microbes governs mutualism, nutrient sharing, and defense. Key molecules like flavonoids, strigolactones, and quorum sensing signals orchestrate microbial recruitment and activity. This session examines how signaling networks are decoded and harnessed to foster beneficial interactions and suppress pathogens.

Track 14: Plant Conditioners (Biostimulants)

Biostimulants enhance plant vigor, yield, and stress resilience without being fertilizers or pesticides. They include microbial inoculants, seaweed extracts, and humic substances. This session explores the mechanisms of biostimulants—from promoting root architecture to influencing gene expression—and their growing role in sustainable farming practices.

Track 15: Arbuscular Mycorrhizal Fungi (AMF)

AMF penetrate plant roots and extend hyphal networks into the soil, increasing uptake of phosphorus, water, and micronutrients. In return, plants supply carbon. This mutualism boosts plant resistance to drought and pathogens. This session highlights AMF diversity, mechanisms, and strategies to integrate AMF into commercial cropping systems.

Track 16: Biostimulants and Biocontrol Strategies

Combining plant-strengthening agents with microbial biocontrol can reduce crop losses and improve soil health. Biocontrol agents suppress pests and diseases using competition, antibiosis, and induced resistance. This session covers the synergistic use of microbial consortia, challenges in formulation, and future directions in organic and integrated agriculture.

Track 17: Bacterial Selection for Biological Control of Plant Disease

Identifying bacteria with disease-suppressing traits is critical for effective biocontrol. Key features include rhizosphere colonization, secondary metabolite production, and compatibility with plant hosts. This session presents strategies for strain selection, genomic screening, and field validation of promising biocontrol agents.

Track 18: Animals in a Bacterial World-A New Imperative for the Life Sciences

Animals evolved in a microbial world, and symbiosis with microbes is essential—not incidental—to their survival. From digestion in ruminants to light production in squid, microbial partnerships shape development, behavior, and evolution. This session reframes biology through the lens of the holobiont—host plus microbiome—highlighting how modern life sciences must integrate microbial ecology to fully understand animal biology.

Track 19: Microbiome- Science Comes to Life

Once an obscure niche, microbiome research has exploded across health, agriculture, and ecology. From gut health to climate change, microbes are now recognized as powerful drivers of life systems. This session provides a panoramic view of microbiome science, celebrating breakthroughs in sequencing, systems biology, and computational tools that have brought the invisible world to center stage.

Track 20: Modulation of Microbiota

Microbiota composition can be shaped through diet, probiotics, prebiotics, synbiotics, antibiotics, and fecal transplants. Understanding how these interventions alter microbial communities opens new therapeutic avenues. This session discusses the principles and pitfalls of microbiota modulation in both humans and plants, with emphasis on resilience, safety, and personalized approaches.

Track 21: Prebiotics and Probiotics

Prebiotics feed beneficial microbes, while probiotics directly supplement them. Used in foods, supplements, and therapeutics, they influence digestion, immunity, and mental health. This session explores the latest in formulation science, strain-specific benefits, and regulatory challenges, along with their use in preventing and managing disease.

Track 22: Pharmacogenomics and the Microbiome

The gut microbiome can modulate drug metabolism, efficacy, and toxicity. It activates or degrades drugs, influences gene expression, and interacts with host enzymes. This session covers how pharmacogenomics is being revolutionized by microbiome data, potentially enabling more precise and personalized medicine.

Track 23: Bioinformatics for Microbiome

High-throughput sequencing has unleashed a flood of microbiome data, requiring advanced bioinformatics to interpret. From 16S rRNA gene analysis to shotgun metagenomics and metatranscriptomics, computational tools help decode microbial taxonomy, function, and interactions. This session showcases platforms, pipelines, and algorithms powering microbiome discovery and clinical translation.

Track 24: 16S Sequencing and Analysis

16S rRNA gene sequencing remains a cornerstone of microbial ecology, allowing identification of bacterial communities from various environments. It offers a cost-effective snapshot of diversity but comes with limitations in resolution and bias. This session explores best practices for 16S workflows—from primer selection to taxonomic classification and statistical analysis.

Track 25: Horticulture Hydroponics and Microbiomes

Hydroponics eliminates soil but not the need for microbial partnerships. Beneficial bacteria in nutrient solutions can promote root growth, prevent disease, and enhance nutrient uptake. This session explores microbial management in hydroponic systems, biocontrol formulations, and microbial adaptation to soilless environments—bringing together clean tech and biological complexity.

Track 26: Benefits of Biostimulants

Biostimulants enhance crop yield, nutrient efficiency, and stress tolerance through hormonal modulation, microbial signaling, and enzymatic activity. They contribute to regenerative agriculture by reducing dependency on chemicals. This session presents case studies on yield improvements, environmental benefits, and regulatory frameworks supporting their use in commercial agriculture.

Track 27: The Globalization of Cannabis Cultivation-A Growing Challenge

As cannabis cultivation expands worldwide, managing plant microbiomes becomes increasingly important for disease control, yield optimization, and product quality. However, inconsistent regulations, microbiome disruptions, and limited research create major challenges. This session explores the need for microbial stewardship, biocontrol innovations, and standardization in the booming cannabis industry.

Market Analysis

The global microbiome market has evolved from academic curiosity to a dynamic, fast-growing sector intersecting health, agriculture, biotechnology, and personalized medicine. It was valued at USD 943 million in 2023 and is projected to reach USD 2.5 billion by 2030, growing at a CAGR of 15–22%, depending on the segment.

This surge is driven by increasing awareness of gut health, the rise in chronic diseases, breakthrough in sequencing technologies, and the explosion of probiotic/prebiotic products. Moreover, microbiome-based therapies are entering clinical phases, attracting significant pharma and biotech investments.

 Sectoral Highlights

a. Human Health Microbiomes

• Therapeutics targeting gut disorders, obesity, diabetes, mental health, and oncology.
• Active clinical trials in microbiome drugs and fecal microbiota transplantation (FMT).
• Major players: Seres Therapeutics, Vedanta Biosciences, Finch Therapeutics.

b. Agricultural Microbiomes

• Use of beneficial microbes to reduce chemical fertilizers and pesticides.
• Demand for biofertilizers, nitrogen-fixing bacteria, AMF, and biostimulants.
• Leaders: Indigo Ag, Pivot Bio, Bioconsortia, Novozymes.

c. Skin & Cosmetic Microbiomes

• Growing market for microbiome-safe skincare, anti-aging formulations, and skin barrier repair.
• Brands include: Gallinée, Mother Dirt, AOBiome.

d. Animal Microbiomes

• Probiotic and microbiome-based feed supplements for livestock and pets.
• Strong adoption in poultry and aquaculture.

e. Bioinformatics & Technology

• High demand for AI-powered sequencing tools and cloud-based microbiome analytics.
• Key tools: CosmosID, QIIME, One Codex, BaseClear.

 Investment Trends

• Over $3 billion in venture capital since 2016.
• Spike in Series A/B funding for therapeutics and agri-biotech.
• Notable IPOs and partnerships with pharma and food giants.
• Increasing government-backed microbiome research initiatives globally.

Regulatory Outlook

• Human therapeutics: Scrutiny by FDA, EMA, and other regulators.
• Agri-microbiomes: Pathway being developed for biofertilizers and microbial biopesticides.
• Skincare and food: Product claims under increasing scientific validation pressure.

Opportunity for Microbiome Conferences

Why Conferences Are in High Demand:

• Scientific Collaboration: Cross-disciplinary nature of microbiome research makes conferences critical for knowledge exchange.
• Start-up Visibility: Hundreds of microbiome start-ups seek platforms to showcase technologies and attract investors.
• Clinical Translation: As therapies move from lab to market, stakeholders need dialogue—regulators, industry, clinicians.
• Investment & Commercialization: Conferences act as launch pads for new products and partnerships.

Ideal Target Audience:

• Researchers, clinicians, microbiologists, agronomists
• Biotech and pharma executives
• Regulatory professionals
• Venture capital and private equity firms
• Tech companies (bioinformatics, sequencing)
• Nutrition, food, cosmetic industry reps

 Regional Insights

• North America

• U.S.

• Canada

• Europe

• U.K.

• Germany

• Rest Of Europe

• Asia Pacific

• China

• Japan

• Rest of Asia Pacific

• Latin America

• Brazil

• Mexico

• Rest of Latin America

• Middle East and Africa

• GCC

• Rest of Middle East and Africa

Market size in North America for Bio stimulants:

North America Bio stimulants market is projected to grow at a CAGR of 9.72% over the forecast period to reach US$716.3 million in 2022. The bio stimulants industry is witnessing considerable growth in the North American region on account of remarkable biotechnological growth in the area of enzymes production, and acid extraction from natural products, and thereby enabling the production of efficient bio stimulants. Moreover, advanced molecular biology and genetic engineering are also assisting for bioreactor-based amino and other acids production. Furthermore, growth in environment conscious consumers is resulting in increased demand for organic food products, and in turn, is boosting the Bio stimulants market in the region.

Finally, the competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Isagro S.p.A, Taminco Corp., Valagro S.p.A, Italopolina S.p.A, and Koppert BV among others. Bio stimulants market has been segmented on the basis of active ingredients, crop type, application, and geography like Europe.

Future Outlook (2025–2030)

• Market will mature from exploratory science to validated therapies and scalable applications.
• Cross-disciplinary conferences, standardization, and big data collaborations will shape the ecosystem.
• Opportunity for early adopters to lead in product development, partnerships, and public engagement.

Conclusion The microbiome industry is entering a golden phase, merging scientific depth with real-world impact. Stakeholders across pharma, agtech, nutrition, and cosmetics have a unique opportunity to lead in the biological frontier that promises to redefine health and sustainability.